Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
Currently, parenteral anticoagulant therapy is considered a standard addition to thrombolytic treatment (TLT) in myocardial infarction (MI). This review analyses the results of the clinical trials demonstrating the benefits of subcutaneous low-molecular heparin enoxaparin therapy (one week before 48...
| Autor principal: | |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Russian |
| Publicado: |
«SILICEA-POLIGRAF» LLC
2009-12-01
|
| Colección: | Кардиоваскулярная терапия и профилактика |
| Materias: | |
| Acceso en línea: | https://cardiovascular.elpub.ru/jour/article/view/1521 |